908601-49-0 (SB-616234A,SB-616234-A)

SB-616234A;SB 616234A;[6-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5-methoxy-2,3-dihydroindol-1-yl]-[4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methanone;hydrochloride;1H-Indole, 6-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-2,3-dihydro-5-methoxy-1-[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]carbonyl]-, monohydrochloride, rel- (9CI);SB 616234-A;SB-616234-A;AKOS040737561;HY-19477;MS-30343;G16100;CS-6686;DA-67455;908601-49-0;

VPWVEPYFVFBHQR-XKFLBXONSA-N

1S/C32H35N5O3.ClH/c1-19-14-26(31-34-22(4)40-35-31)10-11-27(19)23-6-8-24(9-7-23)32(38)37-13-12-25-15-30(39-5)29(16-28(25)37)36-17-20(2)33-21(3)18-36;/h6-11,14-16,20-21,33H,12-13,17-18H2,1-5H3;1H/t20-,21+;

C(C1C=CC(C2C=CC(C3N=C(C)ON=3)=CC=2C)=CC=1)(N1CCC2=CC(=C(N3C[C@H](C)N[C@H](C)C3)C=C12)OC)=O.Cl